High synovial expression of the inhibitory FcγRIIb in rheumatoid arthritis

Table 1 Characteristics of patients

Patient	Category	Diagnosis	RF	Sex/age	Duration of disease	Therapy
1	Early RA	RA	-	M/64	9 mo	None
2	Early RA	RA	+	M/63	3 mo	NSAID
3	Early RA	RA	+	F/77	1.5 mo	None
4	Early RA	RA	ND	M/20	6 mo	NSAID
5	Early RA	RA	+	M/40	11 mo	None
6	Early RA	RA	+	M/54	11 mo	None
7	Early RA	RA	+	F/62	10 mo	NSAID
8	Early RA	RA	+	M/75	18 mo	NSAID
9	Early RA	RA	+	M/82	12 mo	NSAID
10	Early RA	RA	+	M/51	11 mo	NSAID
11	Early RA	RA	+	F/76	12 mo	Salazopyrin
12	Late RA	RA	-	F/47	20 yr	MTX
13	Late RA	RA	+	F/67	40 yr	MTX
14	Late RA	RA	+	F/62	12 yr	MTX, NSAID
15	Late RA	RA	+	F/65	30 yr	MTX, NSAID, Pred
16	Late RA	RA	+	F/63	2 yr	MTX, NSAID, Pred
17	Late RA	RA	+	F/83	11 yr	MTX, Pred
18	Late RA	RA	+	M/38	22 yr	Enbrel, MTX
19	Late RA	RA	+	F/72	44 yr	Cyclosporine, NSAID
20	Late RA	RA	+	F/59	18 yr	Salazopyrin, Glucosamine
21	Late RA	RA	+	M/73	20 yr	Paracetamol
22	Late RA	RA	+	F/59	11 yr	MTX, Remicade
23	Late RA	RA	+	M/69	40 yr	MTX, Pred, Cyclosporine
24	Late RA	RA	+	M/53	7 yr	Pred, NSAID
25	Late RA	RA	+	F/55	4 yr	Remicade
26	Late RA	Juvenile RA	+	F/35	20 yr	MTX, NSAID
27	Glu-study	RA	+	M/53	7 yr	Pred, NSAID
28	Glu-study	RA	+	M/63	3 mo	NSAID
29	Glu-study	RA	-	F/35	20 yr	MTX, NSAID
30	Glu-study	Oligoarthritis	-	M/21	4 mo	None
31	Glu-study	Oligoarthritis	-	M/53	10 yr	None
32	Glu-study	Polyarthritis	-	F/43	12 yr	Pred, NSAID
33	Glu-study	Polyarthritis	+	F/73	2 yr	MTX
34	Glu-study	RA	ND	M/20	6 mo	NSAID
35	Glu-study	RA	+	F/55	4 yr	Remicade

Glu-study, before and after glucocorticoid study; F, female; M, male; mo, month; MTX, methotrexate; ND, not determined; NSAID, non-steroidal anti-inflammatory drugs; Pred, prednisolone; RA, rheumatoid arthritis; RF, rheumatoid factor; yr, year.

ISSN: 1478-6362